Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Hidradenitis suppurativa (HS) devastates quality of life regardless of clinical severity — even patients classified as "mild" report very severe impacts. A Spanish registry study of nearly 1,200 patients found that pain, depression, anxiety, and lesion location matter far more than traditional disease staging. The findings call for a more holistic approach to HS care.
Hidradenitis suppurativa (HS) is widely known as a painful, chronic skin condition — but a new study reveals just how deeply it disrupts patients' lives, even when doctors classify it as clinically mild. Analyzing data from nearly 1,200 patients in the Spanish HS Registry, researchers found that over a third of those with "mild" disease (by standard clinical measures) still reported very severe quality-of-life (QOL) impairment.
What's striking is the disconnect: traditional clinical severity scores showed only a weak correlation with how patients actually felt, while pain intensity showed a much stronger link. Factors like female sex, smoking, anxiety, depression, and lesion location — especially in the groin, genitals, and armpits — were all tied to worse outcomes, suggesting that the full burden of HS goes well beyond what a clinician sees in the exam room.
By the Numbers:
Why it matters: Clinical staging alone doesn't capture the real suffering of HS patients. This study makes a strong case for routinely using patient-reported outcome tools like HiSQOL in clinical practice — ensuring that even "mild" cases receive the comprehensive, biopsychosocial attention they deserve.
